First Trust Advisors LP 10x Genomics, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

A detailed history of First Trust Advisors LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 83,717 shares of TXG stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,717
Previous 10,093 729.46%
Holding current value
$1.32 Million
Previous $196,000 864.29%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$15.71 - $23.49 $1.16 Million - $1.73 Million
73,624 Added 729.46%
83,717 $1.89 Million
Q2 2024

Aug 13, 2024
SELL
$19.45 - $37.37 $11.1 Million - $21.3 Million
-569,791 Reduced 98.26%
10,093 $196,000
Q1 2024

May 13, 2024
BUY
$36.08 - $54.3 $20.4 Million - $30.7 Million
565,532 Added 3940.44%
579,884 $21.8 Million
Q4 2023

Feb 13, 2024
SELL
$34.32 - $57.55 $7.88 Million - $13.2 Million
-229,588 Reduced 94.12%
14,352 $803,000
Q3 2023

Nov 13, 2023
SELL
$40.86 - $62.98 $1.1 Million - $1.7 Million
-26,929 Reduced 9.94%
243,940 $10.1 Million
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $13.5 Million - $15.5 Million
264,247 Added 3990.44%
270,869 $15.1 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $12,789 - $20,195
362 Added 5.78%
6,622 $369,000
Q4 2022

Feb 09, 2023
SELL
$24.4 - $41.3 $62,976 - $106,595
-2,581 Reduced 29.19%
6,260 $228,000
Q3 2022

Nov 14, 2022
SELL
$28.48 - $52.59 $41,666 - $76,939
-1,463 Reduced 14.2%
8,841 $252,000
Q2 2022

Aug 12, 2022
SELL
$36.95 - $82.41 $953,199 - $2.13 Million
-25,797 Reduced 71.46%
10,304 $466,000
Q1 2022

May 13, 2022
SELL
$55.7 - $145.79 $4.21 Million - $11 Million
-75,566 Reduced 67.67%
36,101 $2.75 Million
Q4 2021

Feb 08, 2022
SELL
$135.05 - $182.59 $32.5 Million - $43.9 Million
-240,512 Reduced 68.29%
111,667 $16.6 Million
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $5.43 Million - $7.16 Million
37,268 Added 11.83%
352,179 $51.3 Million
Q2 2021

Aug 16, 2021
BUY
$134.22 - $202.37 $7.75 Million - $11.7 Million
57,735 Added 22.45%
314,911 $61.7 Million
Q1 2021

May 14, 2021
SELL
$140.25 - $196.86 $8.19 Million - $11.5 Million
-58,418 Reduced 18.51%
257,176 $46.5 Million
Q4 2020

Feb 02, 2021
BUY
$126.47 - $163.7 $33.7 Million - $43.6 Million
266,253 Added 539.62%
315,594 $44.7 Million
Q3 2020

Nov 05, 2020
BUY
$87.44 - $125.0 $4.31 Million - $6.17 Million
49,341 New
49,341 $6.15 Million

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email